Chemed Corporation $CHE Shares Bought by California State Teachers Retirement System

California State Teachers Retirement System grew its holdings in Chemed Corporation (NYSE:CHE) by 21.4% during the first quarter, HoldingsChannel.com reports. The fund owned 16,832 shares of the company’s stock after purchasing an additional 2,972 shares during the quarter. California State Teachers Retirement System’s holdings in Chemed were worth $6,358,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in CHE. Geneos Wealth Management Inc. boosted its position in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after purchasing an additional 76 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in Chemed by 67.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock valued at $5,534,000 after purchasing an additional 4,560 shares in the last quarter. Marshall Wace LLP purchased a new position in Chemed in the second quarter valued at about $579,000. Brown Advisory Inc. raised its position in Chemed by 36.9% in the second quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock valued at $267,000 after purchasing an additional 148 shares during the period. Finally, Cerity Partners LLC lifted its stake in shares of Chemed by 237.7% during the second quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock worth $2,165,000 after purchasing an additional 3,133 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity at Chemed

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the sale, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. The trade was a 22.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total value of $1,079,020.00. Following the completion of the transaction, the chief executive officer directly owned 70,418 shares in the company, valued at approximately $37,991,215.18. The trade was a 2.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 3,537 shares of company stock valued at $1,782,654. Insiders own 3.33% of the company’s stock.

Chemed Stock Performance

Chemed stock opened at $545.55 on Thursday. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $551.68. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The company has a market capitalization of $7.13 billion, a price-to-earnings ratio of 27.40, a price-to-earnings-growth ratio of 2.04 and a beta of 0.51. The firm’s fifty day moving average price is $473.28 and its 200 day moving average price is $438.37.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the prior year, the company posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, research analysts forecast that Chemed Corporation will post 23.18 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were paid a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a dividend yield of 0.4%. Chemed’s payout ratio is 12.05%.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Oppenheimer upped their target price on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research report on Friday, July 31st. Royal Bank Of Canada raised their target price on Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a report on Thursday, July 30th. Bank of America reissued a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, Chemed has an average rating of “Hold” and a consensus target price of $530.75.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.